Lombard Odier Asset Management (Europe)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,690
| Closed | -$1.78M | – | 285 |
|
|
2024
Q2 | $1.78M | Buy |
+1,690
| New | +$1.78M | 0.08% | 208 |
|
|
2023
Q2 | – | Sell |
-1,530
| Closed | -$1.26M | – | 283 |
|
|
2023
Q1 | $1.26M | Sell |
1,530
-148
| -9% | -$122K | 0.06% | 215 |
|
|
2022
Q4 | $1.21M | Buy |
+1,678
| New | +$1.21M | 0.05% | 228 |
|
|
2020
Q4 | – | Sell |
-797
| Closed | -$446K | – | 345 |
|
|
2020
Q3 | $446K | Buy |
+797
| New | +$446K | 0.03% | 193 |
|
|
2020
Q2 | – | Sell |
-882
| Closed | -$431K | – | 254 |
|
|
2020
Q1 | $431K | Hold |
882
| – | – | 0.03% | 172 |
|
|
2019
Q4 | $331K | Hold |
882
| – | – | 0.02% | 265 |
|
|
2019
Q3 | $245K | Hold |
882
| – | – | 0.02% | 320 |
|
|
2019
Q2 | $276K | Hold |
882
| – | – | 0.02% | 300 |
|
|
2019
Q1 | $362K | Hold |
882
| – | – | 0.04% | 215 |
|
|
2018
Q4 | $329K | Hold |
882
| – | – | 0.03% | 226 |
|
|
2018
Q3 | $356K | Hold |
882
| – | – | 0.02% | 244 |
|
|
2018
Q2 | $304K | Buy |
882
+120
| +16% | +$41.4K | 0.02% | 254 |
|
|
2018
Q1 | $262K | Sell |
762
-106
| -12% | -$36.4K | 0.02% | 277 |
|
|
2017
Q4 | $326K | Sell |
868
-87
| -9% | -$32.7K | 0.02% | 259 |
|
|
2017
Q3 | $427K | Hold |
955
| – | – | 0.02% | 241 |
|
|
2017
Q2 | $469K | Hold |
955
| – | – | 0.03% | 213 |
|
|
2017
Q1 | $370K | Hold |
955
| – | – | 0.02% | 239 |
|
|
2016
Q4 | $351K | Hold |
955
| – | – | 0.13% | 214 |
|
|
2016
Q3 | $384K | Hold |
955
| – | – | 0.13% | 196 |
|
|
2016
Q2 | $334K | Buy |
+955
| New | +$334K | 0.02% | 257 |
|
|
2015
Q1 | – | Sell |
-1,424
| Closed | -$587K | – | 136 |
|
|
2014
Q4 | $587K | Buy |
+1,424
| New | +$587K | 0.13% | 101 |
|